Analyst Upgrades – Dipexium Pharmaceuticals (NASDAQ:PLXP) Stock Gets Upgraded By Redburn Partners from Outperform to

Analyst Ratings For Dipexium Pharmaceuticals (NASDAQ:PLXP)

Story continues below

Today, Dipexium Pharmaceuticals (NASDAQ:PLXP) stock received an upgrade by Redburn Partners from Outperform.

There are 1 hold rating, 2 buy ratings on the stock.

The current consensus rating on Dipexium Pharmaceuticals (NASDAQ:PLXP) is Buy (Score: 2.67) with a consensus target price of per share, a potential .

Some recent analyst ratings include

  • 8/1/2017-Redburn Partners Upgrade from a “Outperform” rating to a “” rating.
  • 7/31/2017-Raymond James Financial, Inc. Upgrade from a “Market Perform ” rating to a ” Outperform” rating.
  • 10/25/2016-Feltl & Co. was Downgraded by analysts at Feltl & Co. from a “Buy ” rating to a ” Hold” rating.

Recent Insider Trading Activity For Dipexium Pharmaceuticals (NASDAQ:PLXP)
Dipexium Pharmaceuticals (NASDAQ:PLXP) has insider ownership of 47.70% and institutional ownership of 38.86%.

  • On 6/14/2017 David Emerson Jorden, CFO, bought 32,727 with an average share price of $6.88 per share and the total transaction amounting to $225,161.76. View SEC Filing
  • On 6/14/2017 Gary L Mossman, COO, bought 7,273 with an average share price of $6.88 per share and the total transaction amounting to $50,038.24. View SEC Filing
  • On 6/14/2017 Michael J Valentino, Insider, bought 29,091 with an average share price of $6.88 per share and the total transaction amounting to $200,146.08. View SEC Filing
  • On 5/21/2014 Jack H Dean, Director, bought 3,000 with an average share price of $9.00 per share and the total transaction amounting to $27,000.00. View SEC Filing
  • On 3/18/2014 David Garrett, VP, bought 2,083 with an average share price of $12.00 per share and the total transaction amounting to $24,996.00. View SEC Filing
  • On 3/18/2014 Thomas L Harrison, Director, bought 2,000 with an average share price of $12.00 per share and the total transaction amounting to $24,000.00. View SEC Filing

Recent Trading Activity for Dipexium Pharmaceuticals (NASDAQ:PLXP)
Shares of Dipexium Pharmaceuticals closed the previous trading session at 6.40 up +0.20 3.23% with 17,562 shares trading hands.

An ad to help with our costs